Sign In
Buy ETON
$27.61
+0.210 (+0.766%)
At Close: Jun 03, 2026
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:48pm, Wednesday, 04'th Aug 2021
Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone Autoinjector
06:43am, Wednesday, 16'th Jun 2021
Eton Pharmaceuticals Inc (NASDAQ: ETON) has acquired the U.S. and Canadian rights to Crossject's Zeneo hydrocortisone needleless autoinjector. The product is under development as a rescue treatment
CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Crossject's ZENEO® Hydrocortisone
01:30am, Wednesday, 16'th Jun 2021
Press Release
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
04:05pm, Tuesday, 15'th Jun 2021
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), the U.S. marketer of ALKINDI SPRINKLE®, a treatment for adrenocortical insufficiency in pediatric patients
Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres
11:54am, Tuesday, 15'th Jun 2021
The FDA has approved Eton Pharmaceuticals Inc's (NASDAQ: ETON) Rezipres (ephedrine hydrochloride injection) to treat clinically significant hypotension occurring in the setting of anesthesia. Rezip
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
10:37am, Tuesday, 15'th Jun 2021
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres® (ephedrine hydrochl
Eton Pharmaceuticals, Inc. (ETON) Stock Jumps 5.4%: Will It Continue to Soar?
09:01am, Friday, 04'th Jun 2021
Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in
Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection
08:05am, Friday, 28'th May 2021
DEER PARK, Ill., May 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), today announced that the company has received a Complete Response Letter (CRL) from the U.S. Food & Drug Adm
Do Options Traders Know Something About Eton Pharmaceuticals (ETON) Stock We Don't?
09:46am, Tuesday, 25'th May 2021
Investors need to pay close attention to Eton Pharmaceuticals (ETON) stock based on the movements in the options market lately.
Eton Pharmaceuticals, Inc. (ETON) Surges 6.7%: Indication of Further Gains?
03:47pm, Monday, 17'th May 2021
Eton Pharmaceuticals, Inc. (ETON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call Transcript
10:42pm, Thursday, 13'th May 2021
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call Transcript
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Meet Estimates
07:41pm, Thursday, 13'th May 2021
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 0.00% and -1.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the sto
Eton Pharmaceuticals: Q1 Earnings Insights
04:52pm, Thursday, 13'th May 2021
Shares of Eton Pharmaceuticals (NASDAQ:ETON) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 138.00% year over year to $0.19
Eton Pharmaceuticals, Inc. (ETON) Reports Next Week: Wall Street Expects Earnings Growth
03:46pm, Thursday, 06'th May 2021
Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04:05pm, Tuesday, 04'th May 2021
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases,
